Evidence check: Helicobacter in the context of weight loss

Helicobacter pylori (H. pylori) is commonly associated with gastric issues, but its role in weight loss is complex and not well-established. Some studies suggest that H. pylori infection may alter levels of ghrelin and leptin, hormones that regulate appetite and satiety, potentially leading to weight changes. However, the effects are small, inconsistent, and highly dependent on individual factors such as inflammation, gastric acid production, and comorbidities. In clinical practice, H. pylori is not recommended as a weight loss tool. Eradication therapy (antibiotics + proton pump inhibitors) can actually lead to weight gain by relieving dyspepsia and improving food intake. Moreover, H. pylori is a risk factor for gastric cancer and peptic ulcers; treatment should only be given when medically indicated. Direct-to-consumer tests that market H. pylori for weight loss are misleading. The evidence is based on observational studies (human-moderate), not randomized controlled trials. In summary, while H. pylori may influence body weight, the effect is too small and non-specific to guide clinical decisions. A balanced diet and regular exercise remain the cornerstones of weight management.